Nomenclature
Short Name:
ADCK2
    Full Name:
AarF domain containing kinase 2
    Alias:
- BG832130
Classification
Type:
Protein-serine/threonine kinase
    Group:
Atypical
    Family:
ABC1
    SubFamily:
ABC1-C
    Structure
Mol. Mass (Da):
68,982
    # Amino Acids:
626
    # mRNA Isoforms:
1
    mRNA Isoforms:
68,982 Da (626 AA; Q7Z695)
    4D Structure:
NA
    1D Structure:
Subfamily Alignment

Domain Distribution:
| Start | End | Domain | 
|---|---|---|
| 1 | 18 | signal_peptide | 
| 307 | 626 | ABC1 | 
| Pkinase | 
Post-translation Modifications
For detailed information on phosphorylation of this kinase go to PhosphoNET
       Threonine phosphorylated:
T387.
Tyrosine phosphorylated:
Y218.
Distribution
Based on gene microarray analysis from the NCBI
   Human Tissue Distribution
% Max Expression:  
Mean Expression:  
Number of Samples:  
Standard Deviation:  
            % Max Expression:  
Mean Expression:  
Number of Samples:  
Standard Deviation:  
    73 73
 936
 55
 1020
 
 6 6
 76
 23
 56
 
 5 5
 60
 7
 51
 
 33 33
 430
 159
 533
 
 58 58
 742
 47
 648
 
 3 3
 40
 148
 35
 
 4 4
 54
 51
 52
 
 70 70
 908
 53
 1884
 
 41 41
 525
 31
 375
 
 5 5
 65
 124
 89
 
 7 7
 93
 40
 95
 
 69 69
 887
 254
 634
 
 4 4
 48
 51
 41
 
 5 5
 67
 15
 65
 
 6 6
 80
 25
 98
 
 4 4
 58
 28
 44
 
 17 17
 215
 232
 174
 
 7 7
 86
 18
 84
 
 5 5
 63
 142
 54
 
 44 44
 573
 215
 613
 
 14 14
 187
 24
 175
 
 8 8
 105
 32
 104
 
 4 4
 46
 11
 31
 
 5 5
 59
 18
 45
 
 9 9
 116
 24
 118
 
 53 53
 687
 83
 688
 
 5 5
 70
 54
 62
 
 7 7
 85
 18
 60
 
 6 6
 79
 18
 76
 
 7 7
 92
 56
 60
 
 47 47
 607
 36
 798
 
 100 100
 1290
 66
 2658
 
 20 20
 254
 91
 900
 
 78 78
 1000
 104
 741
 
 12 12
 161
 61
 228
 
Evolution
Species Conservation
PhosphoNET % Identity:  
PhosphoNET % Similarity:  
  Homologene %
Identity:  
            PhosphoNET % Identity:  
PhosphoNET % Similarity:  
  Homologene %
Identity:  
    100 100
 100
 100
 98.7 98.7
 99.5
 99
 98.7 98.7
 99.5
 95
 - -
 -
 79
 - -
 -
 -
 95.4 95.4
 97.1
 80.5
 80 80
 86.7
 -
 - -
 -
 76
 74.1 74.1
 82.1
 74
 72.2 72.2
 81.2
 -
 - -
 -
 -
 - -
 -
 62
 55 55
 67.7
 58
 - -
 -
 57
 49.8 49.8
 63.4
 -
 - -
 -
 -
 - -
 -
 -
 - -
 -
 41
 26.7 26.7
 44.9
 -
 38.5 38.5
 55.8
 -
 - -
 -
 -
 - -
 -
 30
 - -
 -
 37
 - -
 -
 38
 21.5 21.5
 38.5
 37
For a wider analysis go to PhosphoNET Evolution in PhosphoNET
    Regulation
Activation:
NA
    Inhibition:
NA
    Synthesis:
NA
    Degradation:
NA
    
Protein Kinase Specificity
Matrix of observed frequency (%) of amino acids in aligned protein substrate phosphosites
      
Matrix Type:
Predicted from the application of the Kinexus Kinase Substrate Predictor Version 2.0 algorithm, which was trained with over 10,000 kinase-protein substrate pairs and 8,000 kinase-peptide substrate pairs.
            Domain #:
1
    Disease Linkage
General Disease Association:
Congenital bone malformation
Specific Diseases (Non-cancerous):
Klippel-Feil Syndrome
Comments:
Klippel-Feil Syndrome is a rare disorder characterized by the congenital fusion of any 2 of the 7 cervical (neck) vertebrae, which is caused by a failure in the normal segmentation or division of the cervical vertebrae during the early weeks of fetal development.  
 
   Gene Expression in Cancers:
The COSMIC website notes an up-regulated expression score for ADCK2 in diverse human cancers of 699, which is 1.5-fold of the average score of 462 for the human protein kinases. The down-regulated expression score of 76 for this protein kinase in human cancers was 1.3-fold of the average score of 60 for the human protein kinases.
Mutagenesis Experiments:
Insertional mutagenesis studies in mice have not yet revealed a role for this protein kinase in mouse cancer oncogenesis.
Mutation Rate in All Cancers:
Percent mutation rates per 100 amino acids length in human cancers: 0.05 % in 24726 diverse cancer specimens. This rate is only -35 % lower than the average rate of 0.075 % calculated for human protein kinases in general.
Mutation Rate in Specific Cancers:
Highest percent mutation rates per 100 amino acids length in human cancers: 0.24 % in 864 skin cancers tested; 0.24 % in 1270 large intestine cancers tested.
Frequency of Mutated Sites:
None >2 in 19643 cancer specimens
Comments:
Only 3 deletions, no insertions and 1 complex mutations are noted on the COSMIC website.
 

